Last updated: February 19, 2024
Sponsor: Stephanie McCrory
Overall Status: Active - Recruiting
Phase
N/A
Condition
Insomnia
Treatment
Strathclyde intervention to encourage good sleep health for teenagers (SIESTA)
Strathclyde Sleep Intervention
Clinical Study ID
NCT05870228
UEC2331
Ages 12-15 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adolescents (12-15 years)
- Meeting thresholds for insomnia disorder (determined by cut-off scores on the 2 itemSleep Condition Indicator (score <2 indicates probable insomnia)
- Attending CAMHS for mental health intervention/support
- Able to engage with intervention protocol
Exclusion
Exclusion Criteria:
- Active suicide ideation and/or recent suicidal attempts
- Contraindicators for components of CBT-I (sleep restriction therapy) including seizuredisorders/conditions including epilepsy, bipolar disorder, symptoms of psychosis,obstructive sleep apnea and parasomnias.
- Diagnosis of Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder,Foetal Alcohol Spectrum Disorder (Neurodiversity)
- Those who are currently completing, or have recently completed (in the past 6 months),CBT-I for insomnia elsewhere (or components of CBT-I including e.g. sleep restrictiontherapy, stimulus control, cognitive techniques). This will only include in-person,one-to-one methods of delivery
Study Design
Total Participants: 46
Treatment Group(s): 2
Primary Treatment: Strathclyde intervention to encourage good sleep health for teenagers (SIESTA)
Phase:
Study Start date:
October 13, 2023
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
East Renfrewshire Healthier Minds Team
Glasgow, Lanarkshire g781sy
United KingdomActive - Recruiting
Ayrshire and Arran Child and Adolescent Mental Health Services
Irvine,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.